Antibiotic (Lincosamide) — Surgical Prophylaxis
Pregnancy: B — used when benefit outweighs risk; safe in obstetric use
Clindamycin (Surgical Prophylaxis — Penicillin Allergy)
Brand names: Dalacin C
Adult dose
Dose: Surgical prophylaxis: 600 mg IV at induction. Treatment of SSI/soft tissue infections: 600–900 mg IV every 8h, or 150–450 mg oral every 6h
Route: IV or oral
Frequency: Single dose (prophylaxis); every 6–8h (treatment)
Max: 2.7 g/day (IV treatment); 1.8 g/day (oral)
First-line alternative surgical prophylaxis in patients with penicillin or cephalosporin allergy. WHO SSI guidelines 2016: clindamycin + gentamicin as alternative to beta-lactam prophylaxis. Active against Gram-positive cocci (MRSA, streptococci) and anaerobes. No Gram-negative coverage — add gentamicin if Gram-negative cover needed.
Paediatric dose
Dose: 10 mg/kg
Route: IV or oral
Frequency: Every 6–8h
Max: 40 mg/kg/day
Concentration: 150 mg/mL (IV); 75 mg/5 mL (oral) mg/ml
Children: 10 mg/kg every 6–8h IV. Neonates: 5–7.5 mg/kg every 8h (caution — benzyl alcohol in some preparations).
Dose adjustments
Renal
No dose adjustment required
Hepatic
Reduce dose in severe hepatic impairment (prolonged half-life)
Paediatric weight-based calculator
Children: 10 mg/kg every 6–8h IV. Neonates: 5–7.5 mg/kg every 8h (caution — benzyl alcohol in some preparations).
Clinical pearls
- Highest C. difficile risk of all antibiotics — limit to penicillin-allergic patients for surgical prophylaxis; use single dose only
- MSSA and MRSA coverage: excellent Gram-positive activity including many MRSA strains (check local susceptibility)
- Oesophagitis risk: oral clindamycin capsules cause oesophageal injury if not taken with sufficient fluid (200 mL) and remaining upright
- No Gram-negative cover: always combine with gentamicin if broad-spectrum prophylaxis needed (e.g., colorectal surgery in penicillin-allergic patient)
- Single prophylactic dose: repeat only if surgery >4h or blood loss >1.5L (same as other surgical prophylaxis agents)
Contraindications
- Hypersensitivity to clindamycin or lincomycin
- Diarrhoeal illness (risk of C. difficile)
Side effects
- Clostridium difficile-associated diarrhoea (highest risk of any antibiotic class)
- Diarrhoea
- Nausea
- Rash
- Oesophagitis (oral — take with large glass of water, remain upright)
Interactions
- Neuromuscular blocking agents — potentiates blockade
- Erythromycin — antagonism (same ribosomal binding site — avoid combination)
Monitoring
- Diarrhoea (C. difficile — especially if course >5 days)
- Renal and hepatic function (prolonged courses)
- Neuromuscular function (if NMBAs co-administered)
Reference: BNFc; WHO SSI Guidelines 2016; BNF; PHE Penicillin Allergy Guidance; SIGN 104. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Caprini Score for VTE Risk (2005) · VTE Risk
- EuroSCORE II · Surgical Risk
- Thakar Score for AKI after Cardiac Surgery · Surgical Risk
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH